查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
日光角化症治療的全球市場規模調查:各治療法，藥物類別，各最終用途，各地區預測(2022年～2028年)
市場調查報告書
商品編碼
1099738

日光角化症治療的全球市場規模調查:各治療法，藥物類別，各最終用途，各地區預測(2022年～2028年)

Global Actinic Keratosis Treatment Market Size study, By Therapy, By Drug Class, By End-use, and Regional Forecasts 2022-2028
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

光化性角化病患病率的增加、對該疾病的認識提高以及市場領先公司的戰略舉措是推動對光化性角化病治療市場需求不斷增長的因素。

此外，老年人口的增加和醫療領域研發活動的激活也有望成為刺激市場需求的因素。

本報告提供全球日光角化症治療市場相關調查分析，提供市場動態，產業分析，市場分析，競爭資訊等系統性資訊。

目錄

第1章 摘要整理

第2章 全球日光角化症治療市場定義和範圍

第3章 全球日光角化症治療市場動態

  • 日光角化症治療市場影響分析(2020年～2028年)

第4章 全球日光角化症治療市場產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論
  • 主要投資機會
  • 主要成功策略

第5章 風險評估:COVID-19影響

  • COVID-19對產業的整體影響評估
  • COVID-19前及COVID-19後的市場方案

第6章 全球日光角化症治療市場:各治療法

  • 市場概述
  • 全球日光角化症治療市場實際成果:各治療法-潛在分析
  • 全球日光角化症治療市場估計和預測(100萬美元)(2018年～2028年):各治療法
  • 日光角化症治療市場，子區隔分析
    • 局部
    • 手術
    • 光線動態療法

第7章 全球日光角化症治療市場:各類藥物

  • 市場概述
  • 全球日光角化症治療市場實際成果:各類藥物-潛在分析
  • 全球日光角化症治療市場估計和預測(100萬美元)(2018年～2028年):各類藥物
  • 日光角化症治療市場，子區隔分析
    • 核甘代謝抑制劑
    • NSAID
    • 免疫應答修飾因素
    • 光增強劑
    • 其他

第8章 全球日光角化症治療市場:各最終用途

  • 市場概述
  • 全球日光角化症治療市場實際成果:各最終用途-潛在分析
  • 全球日光角化症治療市場估計和預測(100萬美元)(2018年～2028年):各最終用途
  • 日光角化症治療市場，子區隔分析
    • 醫院
    • 私人診所
    • 居家醫療
    • 其他

第9章 全球日光角化症治療市場，地區分析

  • 地區的市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他的歐洲
  • 亞太地區概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他的亞太地區
  • 南美概述
    • 巴西
    • 墨西哥
  • 其他

第10章 競爭資訊

  • 主要市場策略
  • 企業簡介
    • Sun Pharmaceuticals Industries Ltd.
    • Novartis AG
    • GALDERMA
    • Hill Dermaceuticals, Inc.
    • Viatris Inc.
    • Mylan N.V.
    • Bausch Health Companies, Inc.
    • LEO Pharma A/S
    • Almirall, S.A.
    • Biofrontera AG

第11章 調查流程

Global Actinic Keratosis Treatment Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The Actinic Keratosis refers to an abnormal growth of cells caused by long-term damage from the sun. In this condition skin develops rough, scaly patch. face, lips, ears, forearms, scalp, neck or back of the hands are largely affected by Actinic Keratosis. The rising prevalence of actinic keratosis disease and growing awareness towards the disease as well as recent strategic initiatives from leading market players are factors that are accelerating the global market demand. For instance, according to Skin Cancer Foundation, USA - as of 2020, Actinic keratosis is the most prevalent precancer and it affects around 58 million Americans. Furthermore, leading market players are coming up with innovative treatment products to leverage the increasing demand for actinic keratosis treatment solutions. For instance, in June 2020, India based Sun Pharmaceutical Industries Ltd. launched Levulan Kerastick. This new product is a topical solution for the treatment of mild to moderate actinic keratosis of the scalp, face, and upper extremities. Moreover, in September 2021, Athenex announced phased Launch of its novel topical microtubule inhibitor named Klisyri® (tirbanibulin) for the treatment of Actinic Keratosis. This new product is approved by the UK Medicines and Healthcare products Regulatory Agency and would be available for prescription in the UK and Germany. Also, rising geriatric population and growing research & development activities in healthcare sector are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, high cost associated with treatment of actinic keratosis and complex process of regulatory approvals impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Actinic Keratosis Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing incidences of the diseases and recent regulatory approvals in the region. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as the thriving growth of healthcare sector and increasing penetration of leading market players in the region, would create lucrative growth prospects for the global Actinic Keratosis Treatment Market across the Asia Pacific region.

Major market players included in this report are:

Sun Pharmaceutical Industries Ltd.

Novartis AG

GALDERMA

Hill Dermaceuticals, Inc.

Viatris Inc.

Mylan N.V.

Bausch Health Companies, Inc.

LEO Pharma A/S

Almirall, S.A.

Biofrontera AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy

Topical

Surgery

Photodynamic Therapy

By Drug Class

Nucleoside Metabolic Inhibitor

NSAIDs

Immune Response Modifiers

Photoenhancers

Others

By End-use

Hospitals

Private Clinics

Homecare

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Actinic Keratosis Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Global Actinic Keratosis Treatment Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Global Actinic Keratosis Treatment Market, by Therapy, 2020-2028 (USD Million)
    • 1.2.3. Global Actinic Keratosis Treatment Market, by Drug Class, 2020-2028 (USD Million)
    • 1.2.4. Global Actinic Keratosis Treatment Market, by End Use, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Actinic Keratosis Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Actinic Keratosis Treatment Market Dynamics

  • 3.1. Actinic Keratosis Treatment Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of actinic keratosis disease.
      • 3.1.1.2. Growing awareness towards the disease.
      • 3.1.1.3. Recent strategic initiatives from leading market players.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High treatment cost.
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising geriatric population.
      • 3.1.3.2. Growing research & development activities in healthcare sector.

Chapter 4. Global Actinic Keratosis Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Actinic Keratosis Treatment Market, by Therapy

  • 6.1. Market Snapshot
  • 6.2. Global Actinic Keratosis Treatment Market by Therapy, Performance - Potential Analysis
  • 6.3. Global Actinic Keratosis Treatment Market Estimates & Forecasts by Therapy 2018-2028 (USD Million)
  • 6.4. Actinic Keratosis Treatment Market, Sub Segment Analysis
    • 6.4.1. Topical
    • 6.4.2. Surgery
    • 6.4.3. Photodynamic Therapy

Chapter 7. Global Actinic Keratosis Treatment Market, by Drug Class

  • 7.1. Market Snapshot
  • 7.2. Global Actinic Keratosis Treatment Market by Drug Class, Performance - Potential Analysis
  • 7.3. Global Actinic Keratosis Treatment Market Estimates & Forecasts by Drug Class 2018-2028 (USD Million)
  • 7.4. Actinic Keratosis Treatment Market, Sub Segment Analysis
    • 7.4.1. Nucleoside Metabolic Inhibitor
    • 7.4.2. NSAIDs
    • 7.4.3. Immune Response Modifiers
    • 7.4.4. Photoenhancers
    • 7.4.5. Others

Chapter 8. Global Actinic Keratosis Treatment Market, by End Use

  • 8.1. Market Snapshot
  • 8.2. Global Actinic Keratosis Treatment Market by End Use, Performance - Potential Analysis
  • 8.3. Global Actinic Keratosis Treatment Market Estimates & Forecasts by End Use 2018-2028 (USD Million)
  • 8.4. Actinic Keratosis Treatment Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Private Clinics
    • 8.4.3. Homecare
    • 8.4.4. Others

Chapter 9. Global Actinic Keratosis Treatment Market, Regional Analysis

  • 9.1. Actinic Keratosis Treatment Market, Regional Market Snapshot
  • 9.2. North America Actinic Keratosis Treatment Market
    • 9.2.1. U.S. Actinic Keratosis Treatment Market
      • 9.2.1.1. Therapy estimates & forecasts, 2018-2028
      • 9.2.1.2. Drug Class estimates & forecasts, 2018-2028
      • 9.2.1.3. End Use estimates & forecasts, 2018-2028
    • 9.2.2. Canada Actinic Keratosis Treatment Market
  • 9.3. Europe Actinic Keratosis Treatment Market Snapshot
    • 9.3.1. U.K. Actinic Keratosis Treatment Market
    • 9.3.2. Germany Actinic Keratosis Treatment Market
    • 9.3.3. France Actinic Keratosis Treatment Market
    • 9.3.4. Spain Actinic Keratosis Treatment Market
    • 9.3.5. Italy Actinic Keratosis Treatment Market
    • 9.3.6. Rest of Europe Actinic Keratosis Treatment Market
  • 9.4. Asia-Pacific Actinic Keratosis Treatment Market Snapshot
    • 9.4.1. China Actinic Keratosis Treatment Market
    • 9.4.2. India Actinic Keratosis Treatment Market
    • 9.4.3. Japan Actinic Keratosis Treatment Market
    • 9.4.4. Australia Actinic Keratosis Treatment Market
    • 9.4.5. South Korea Actinic Keratosis Treatment Market
    • 9.4.6. Rest of Asia Pacific Actinic Keratosis Treatment Market
  • 9.5. Latin America Actinic Keratosis Treatment Market Snapshot
    • 9.5.1. Brazil Actinic Keratosis Treatment Market
    • 9.5.2. Mexico Actinic Keratosis Treatment Market
  • 9.6. Rest of The World Actinic Keratosis Treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Sun Pharmaceuticals Industries Ltd.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Novartis AG
    • 10.2.3. GALDERMA
    • 10.2.4. Hill Dermaceuticals, Inc.
    • 10.2.5. Viatris Inc.
    • 10.2.6. Mylan N.V.
    • 10.2.7. Bausch Health Companies, Inc.
    • 10.2.8. LEO Pharma A/S
    • 10.2.9. Almirall, S.A.
    • 10.2.10. Biofrontera AG

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Actinic Keratosis Treatment Market, report scope
  • TABLE 2. Global Actinic Keratosis Treatment Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global Actinic Keratosis Treatment Market estimates & forecasts by Therapy 2018-2028 (USD Million)
  • TABLE 4. Global Actinic Keratosis Treatment Market estimates & forecasts by Drug Class 2018-2028 (USD Million)
  • TABLE 5. Global Actinic Keratosis Treatment Market estimates & forecasts by End Use 2018-2028 (USD Million)
  • TABLE 6. Global Actinic Keratosis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 7. Global Actinic Keratosis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Actinic Keratosis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Actinic Keratosis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Actinic Keratosis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Actinic Keratosis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Actinic Keratosis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Actinic Keratosis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Actinic Keratosis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. Global Actinic Keratosis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. U.S. Actinic Keratosis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 17. U.S. Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 18. U.S. Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 19. Canada Actinic Keratosis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 20. Canada Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. Canada Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 22. UK Actinic Keratosis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 23. UK Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. UK Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 25. Germany Actinic Keratosis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 26. Germany Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. Germany Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 28. RoE Actinic Keratosis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 29. RoE Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. RoE Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 31. China Actinic Keratosis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 32. China Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. China Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 34. India Actinic Keratosis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 35. India Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. India Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 37. Japan Actinic Keratosis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 38. Japan Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. Japan Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 40. RoAPAC Actinic Keratosis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. RoAPAC Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 43. Brazil Actinic Keratosis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 44. Brazil Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Brazil Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 46. Mexico Actinic Keratosis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 47. Mexico Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. Mexico Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 49. RoLA Actinic Keratosis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 50. RoLA Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. RoLA Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 52. Row Actinic Keratosis Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 53. Row Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. Row Actinic Keratosis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 55. List of secondary sources, used in the study of global Actinic Keratosis Treatment Market
  • TABLE 56. List of primary sources, used in the study of global Actinic Keratosis Treatment Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Actinic Keratosis Treatment Market, research methodology
  • FIG 2. Global Actinic Keratosis Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Actinic Keratosis Treatment Market, key trends 2021
  • FIG 5. Global Actinic Keratosis Treatment Market, growth prospects 2022-2028
  • FIG 6. Global Actinic Keratosis Treatment Market, porters 5 force model
  • FIG 7. Global Actinic Keratosis Treatment Market, pest analysis
  • FIG 8. Global Actinic Keratosis Treatment Market, value chain analysis
  • FIG 9. Global Actinic Keratosis Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Actinic Keratosis Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Actinic Keratosis Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Actinic Keratosis Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Actinic Keratosis Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Actinic Keratosis Treatment Market, regional snapshot 2018 & 2028
  • FIG 15. North America Actinic Keratosis Treatment Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Actinic Keratosis Treatment Market 2018 & 2028 (USD Million)
  • FIG 17. Asia pacific Market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Actinic Keratosis Treatment Market 2018 & 2028 (USD Million)
  • FIG 19. Global Actinic Keratosis Treatment Market, company Market share analysis (2021)